chr1-39684540-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP3BP4
The NM_016257.4(HPCAL4):āc.64T>Cā(p.Phe22Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000207 in 1,613,156 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00015 ( 0 hom., cov: 32)
Exomes š: 0.00021 ( 1 hom. )
Consequence
HPCAL4
NM_016257.4 missense
NM_016257.4 missense
Scores
6
9
4
Clinical Significance
Conservation
PhyloP100: 9.18
Genes affected
HPCAL4 (HGNC:18212): (hippocalcin like 4) The protein encoded by this gene is highly similar to human hippocalcin protein and hippocalcin like-1 protein. It also has similarity to rat neural visinin-like Ca2+-binding protein-type 1 and 2 proteins. This encoded protein may be involved in the calcium-dependent regulation of rhodopsin phosphorylation. The transcript of this gene has multiple polyadenylation sites. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Cadd, MutationAssessor, phyloP100way_vertebrate, PrimateAI, PROVEAN [when max_spliceai, FATHMM_MKL, M_CAP, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.29445547).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPCAL4 | NM_016257.4 | c.64T>C | p.Phe22Leu | missense_variant | 2/4 | ENST00000372844.8 | NP_057341.1 | |
HPCAL4 | NM_001282396.2 | c.64T>C | p.Phe22Leu | missense_variant | 3/5 | NP_001269325.1 | ||
HPCAL4 | NM_001282397.2 | c.64T>C | p.Phe22Leu | missense_variant | 2/3 | NP_001269326.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPCAL4 | ENST00000372844.8 | c.64T>C | p.Phe22Leu | missense_variant | 2/4 | 1 | NM_016257.4 | ENSP00000361935.3 | ||
HPCAL4 | ENST00000617690.2 | c.64T>C | p.Phe22Leu | missense_variant | 3/5 | 5 | ENSP00000481834.1 | |||
HPCAL4 | ENST00000612703.3 | c.64T>C | p.Phe22Leu | missense_variant | 2/3 | 2 | ENSP00000484070.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 151888Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
23
AN:
151888
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000236 AC: 59AN: 250302Hom.: 0 AF XY: 0.000251 AC XY: 34AN XY: 135342
GnomAD3 exomes
AF:
AC:
59
AN:
250302
Hom.:
AF XY:
AC XY:
34
AN XY:
135342
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000213 AC: 311AN: 1461150Hom.: 1 Cov.: 33 AF XY: 0.000224 AC XY: 163AN XY: 726892
GnomAD4 exome
AF:
AC:
311
AN:
1461150
Hom.:
Cov.:
33
AF XY:
AC XY:
163
AN XY:
726892
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000151 AC: 23AN: 152006Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74282
GnomAD4 genome
AF:
AC:
23
AN:
152006
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
74282
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
28
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.64T>C (p.F22L) alteration is located in exon 2 (coding exon 1) of the HPCAL4 gene. This alteration results from a T to C substitution at nucleotide position 64, causing the phenylalanine (F) at amino acid position 22 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;M;M
PrimateAI
Pathogenic
T
PROVEAN
Pathogenic
.;.;D
REVEL
Uncertain
Sift
Uncertain
.;.;D
Sift4G
Uncertain
D;D;D
Polyphen
P;B;B
Vest4
MutPred
Gain of disorder (P = 0.0863);Gain of disorder (P = 0.0863);Gain of disorder (P = 0.0863);
MVP
MPC
0.72
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at